Washed Microbiota Transplantation Alleviates Diabetic Gastrointestinal Motility Disorders: an Efficacy and Safety Study
Conditions: Diabetic Gastroparesis; Diabetic Gastropathy; Diabetic Gastroenteropathy; Diabetic Gastroparesis Associated With Type 2 Diabetes Mellitus Interventions: Other: Washing Microbiota Transplantation Sponsors: The Second Hospital of Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients
Conditions: B-cell Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia, in Relapse; Refractory Acute Lymphoid Leukemia Interventions: Drug: CD19 CAR T-cell; Drug: CD22 CAR T cells; Procedure: hematopoietic stem-cell transplantation Sponsors: Beijing GoBroad Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation
Conditions: Acute B-cell Lymphoblastic Leukemia Interventions: Drug: Blinatumomab Sponsors: Suping ZHANG Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Neohepatic Albumin-Bilirubin Scores on Renal Outcomes in Living-donor Liver Transplantation Recipients
Conditions: Acute Kidney Injury; Chronic Kidney Diseases; Graft Failure Sponsors: Asan Medical Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Washed Microbiota Transplantation for Diabetic Gastroparesis
Conditions: Diabetic Gastroparesis Interventions: Other: washed microbiota transplantation; Other: placebo Sponsors: The Second Hospital of Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
HCMV Breakthrough Infections During Letermovir Prophylaxis
Conditions: Cytomegalovirus Infections; Cytomegalovirus Viremia; Hematopoietic Stem Cell Transplantation Interventions: Diagnostic Test: Determination of HCMV DNA in plasma after DNAse digestion.; Diagnostic Test: Determination of HCMV DNA in blood or plasma. Sponsors: Foundation IRCCS San Matteo Hospital; Ministero della Salute, Italy Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
A single-center, open-labeled, randomized, 6-month, parallel-group study to assess the safety and efficacy of allogeneic cultured keratinocyte sheet transplantation for deep second-degree burn wounds: rationale and design of phase I/II clinical trial
This study will explain the design and rationale of a cellular-based skin substitute for the first time in Iran. In addition, this work proposes this product being registered as an off-the-shelf product for burn wound management in the country.Trial registrationIranian Registry of Clinical Trials (IRCT) IRCT20080728001031N31, 2022-04-23 for phase I and IRCT20080728001031N36, 2024-03-15 for phase II. (Source: Trials)
Source: Trials - April 1, 2024 Category: Research Source Type: clinical trials
Tacrolimus and Personalized Therapy to Prevent Acute Rejection Episodes
Conditions: Heart Transplant Failure Interventions: Drug: Tacrolimus （FK506） Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Use of DNA Testing and Gene Expression Profiling to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression
Conditions: Kidney Transplant Immunosuppression Interventions: Diagnostic Test: Allosure and TruGraf Sponsors: University of Texas Southwestern Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndromes Interventions: Drug: Venetoclax; Drug: Decitabine; Drug: Fludarabine; Drug: Busulfan; Radiation: Total Body Irradiation Sponsors: Northside Hospital, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma Interventions: Drug: INCB099280 Sponsors: Abramson Cancer Center at Penn Medicine; Incyte Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study
Conditions: Bladder Disease; Bladder, Neurogenic; Bladder Cancer; Kidney Failure Interventions: Procedure: Bladder Transplantation; Procedure: Combined Kidney and Bladder Transplantation Sponsors: University of California, Los Angeles Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Fecal Microbiota Transplantation (FMT) as a Prophylaxis of Necrotizing Enterocolitis (NEC) - Clinical Study
Conditions: Necrotizing Enterocolitis Interventions: Drug: Fecal Microbiota Transplantation Sponsors: Medical University of Warsaw Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials
Evaluation of an Internet Based Education and Support Program for Patients Awaiting Kidney Transplantation
Conditions: Chronic Kidney Diseases Interventions: Behavioral: Internet based education and support program for patients awaiting kidney transplantation Sponsors: Linkoeping University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials
Faecal Microbiota Transplantation Against Chronic Diarrhea in Patients With Systemic Sclerosis
Conditions: Diarrhea; Systemic Sclerosis Interventions: Procedure: Faecal Microbiota Transplantation (FMT); Procedure: Placebo Sponsors: University of Aarhus Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials
